Unknown

Dataset Information

0

SARS-CoV-2 vaccination and phase 1 cancer clinical trials.

ABSTRACT:

SUBMITTER: Yap TA 

PROVIDER: S-EPMC7906739 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Structures from "Engineering Neutralizing SARS-CoV Antibodies to Bind SARS-CoV-2"
| S-BSST379 | biostudies-other
Unknown Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination
| S-SCDT-EMM-2022-15888P | biostudies-other
Unknown COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials.
| S-EPMC9250750 | biostudies-literature
Transcriptomics Gene expression on SARS CoV-2 specific CD8 T cells after SARS CoV-2 vaccination
2021-08-11 | GSE173567 | GEO
Unknown A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
| S-EPMC7177898 | biostudies-literature
Unknown SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
| S-EPMC7816567 | biostudies-literature
Unknown Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin
| S-SCDT-EMM-2021-14122 | biostudies-other
Unknown Suspension of accrual in phase II cancer clinical trials.
| S-EPMC4355337 | biostudies-literature
Unknown Updating Reports of Phase 3 Clinical Trials for Cancer.
| S-EPMC7863013 | biostudies-literature
Unknown [Rationale of a third SARS-CoV-Vaccination].
| S-EPMC8483803 | biostudies-literature